Recommendations of diagnosis and treatment of gout in China
10.3760/cma.j.cn112138-20200327-00306
- VernacularTitle:痛风诊疗规范
- Author:
Dong XU
1
;
Xiaoxia ZHU
;
Xuejun ZENG
;
Hejian ZOU
;
Jieruo GU
;
Jingguo ZHOU
;
Xiaofeng ZENG
;
Yan ZHAO
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 100730
- From:
Chinese Journal of Internal Medicine
2020;59(6):421-426
- CountryChina
- Language:Chinese
-
Abstract:
Gout is a crystal associated arthritis caused by monosodium urate (MSU) accumulating in joint, and it belongs to metabolic rheumatic disease. In China, gout is common but it is insufficient for education of standardized diagnosis and treatment for gout. Based on the evidence and guidelines from China and other countries, Chinese gout Collaborative Research Group developed standardization of diagnosis and treatment of gout in China. The purpose is to standardize the methods for diagnosis of gout, treatment opportunity and strategies in order to reduce misdiagnosis, missed diagnosis and irreversible damage.
